Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic heart failure. We checked if FGF23 concentration could be modified in patients with end stage liver disease (ESLD) and predict mortality. We m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dominique Prié, Anne Forand, Claire Francoz, Caroline Elie, Isabelle Cohen, Marie Courbebaisse, Dominique Eladari, Didier Lebrec, François Durand, Gerard Friedlander
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science (PLoS) 2013-01-01
Colecção:PLoS ONE
Acesso em linha:http://europepmc.org/articles/PMC3692511?pdf=render
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados